Form 4 for USPH U S PHYSICAL THERAPY INC /NV
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-02 · accession 0001209191-23-015149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-03 | 2023-03-02 | USPH | Binstein Richard | EVP Gen'l Counsel, Sec | S - Sale | $100.78 | -911 | 9,906 | -8% | -$91.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-02 | S | D | 911 | $100.78 | 9,906 | D | — | — | (F1) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.71 to $100.90, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. (F2) Includes 9,906 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 968 shares on each of April 1, 2023, July 1, 2023, October 1, 2023, and on January 1, 2024; 733 shares on each of April 1, 2024, July 1,2024, and October 1, 2024; 734 shares on January 1, 2025; 539 shares on each of April 1, 2025, July 1, 2025 and October 1, 2025; 542 shares on January 1, 2026 and 234 shares on April 1, 2026, if he is an employee of the Company on those dates. |